SCHEMBL5196102

SCHEMBL5196102

CC(O)C#Cc1cc2ccccc2s1

nearest known ligand 0.60

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ALOX5 P09917 4/20 0.60
GRM5 P41594 1/20 0.50
ACACB O00763 1/20 0.42
CYP2A6 P11509 1/20 0.40
MGLL Q99685 1/20 0.40
CYP1A2 P05177 2/20 0.39
PTGES O14684 1/20 0.39
LMNA P02545 1/20 0.39
LTA4H P09960 1/20 0.39
GAA P10253 1/20 0.39
ALOX15 P16050 1/20 0.39
ALOX12 P18054 1/20 0.39
ALOX5AP P20292 1/20 0.39
LOX P28300 1/20 0.39
EPHX2 P34913 1/20 0.39
PTGS2 P35354 1/20 0.39
LTB4R Q15722 1/20 0.39
BCL2L1 Q07817 1/20 0.39
APP P05067 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26080896 0.86 ALOX5 (0.56) ALOX5GRM5CYP2A6MGLLBCL2L1
SCHEMBL12884269 0.76 GRM5 (0.60) ALOX5GRM5CYP2A6MGLLBCL2L1
SCHEMBL9049119 0.76 ALOX5 (1.00) ALOX5ACACBCYP1A2PTGESLMNA
SCHEMBL12884270 0.74 GRM5 (0.58) ALOX5GRM5CYP2A6MGLLBCL2L1
SCHEMBL12884267 0.73 GRM5 (0.57) ALOX5GRM5CYP2A6MGLLBCL2L1
SCHEMBL4807743 0.72 GRM5 (0.60) ALOX5GRM5CYP2A6MGLLBCL2L1
SCHEMBL9203796 0.71 GRM5 (0.59) ALOX5GRM5CYP2A6MGLLBCL2L1
SCHEMBL1444769 0.69 ALOX5 (0.55) ALOX5CYP2A6CYP1A2PTGESLMNA
SCHEMBL9208830 0.69 GRM5 (0.53) ALOX5GRM5CYP2A6MGLLBCL2L1
SCHEMBL12083710 0.69 TSHR (0.47) ALOX5CYP1A2LMNAGAAALOX15

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1812387-A1 2,3,4-SUBSTITUTED CYCLOPENTANONES AS THERAPEUTIC AGENTS Allergan, Inc. (US) 2007-08-01 EP disclosed
WO-2006055481-A1 2,3,4-SUBSTITUTED CYCLOPENTANONES AS THERAPEUTIC AGENTS ALLERGAN , INC. (US) 2006-05-26 WO disclosed